Overview
David Perry is a Hematologist Oncology specialist and an Oncologist in Washington, Washington, D.c.. Dr. Perry is rated as an Experienced provider by MediFind in the treatment of Liver Cancer. His top areas of expertise are Colorectal Cancer, Familial Colorectal Cancer, Anal Cancer, and Pancreatic Cancer.
His clinical research consists of co-authoring 2 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Liver Cancer.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- HMO
- POS
- PPO
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
2 Clinical Trials
Tim Greten is a Hematologist Oncology provider in Bethesda, Maryland. Dr. Greten is rated as a Distinguished provider by MediFind in the treatment of Liver Cancer. His top areas of expertise are Liver Cancer, Cholangiocarcinoma (Bile Duct Cancer), Fibrolamellar Carcinoma, Vagotomy, and Hepatectomy.
Skip Viragh Outpatient Cancer Center
Dr. Mark Yarchoan is a physician–scientist based in Baltimore who specializes in the treatment and study of gastrointestinal cancers, with a particular focus on liver malignancies, including hepatocellular carcinoma (HCC) and cholangiocarcinoma (CCA). He received his undergraduate degree from Amherst College and his medical degree from the Perelman School of Medicine at the University of Pennsylvania. He completed his residency in internal medicine at the Hospital of the University of Pennsylvania, followed by a fellowship in medical oncology at the Johns Hopkins University School of Medicine, where he joined the faculty in 2018. Dr. Yarchoan leads a research laboratory dedicated to developing novel immunotherapies for liver cancers. His translational research program integrates analyses of clinical trial biospecimens with preclinical modeling to identify and overcome barriers to effective antitumor immunity. A major focus of his work is the development of therapeutic cancer vaccines for hepatobiliary malignancies. He serves as Principal Investigator on multiple clinical trials for hepatobiliary cancers, contributes to international guideline committees for liver cancer, and is a member of the Johns Hopkins Graduate Training Programs in Cellular and Molecular Medicine and Immunology. Dr. Yarchoan’s contributions have been recognized with numerous honors, including the ASCO Young Investigator Award, the Conquer Cancer Foundation Career Development Award, the Mark R. Clements Award from the Cholangiocarcinoma Foundation, and the Blue Faery Award for Excellence in Liver Cancer Research. Dr. Yarchoan is rated as a Distinguished provider by MediFind in the treatment of Liver Cancer. His top areas of expertise are Fibrolamellar Carcinoma, Cholangiocarcinoma (Bile Duct Cancer), Liver Cancer, Pancreatic Cancer, and Hepatectomy.
Inova Health Care Services
Timothy Cannon is an Oncologist and a Hematologist in Falls Church, Virginia. Dr. Cannon is rated as a Distinguished provider by MediFind in the treatment of Liver Cancer. His top areas of expertise are Colorectal Cancer, Pancreatic Cancer, Familial Pancreatic Cancer, and Cholangiocarcinoma (Bile Duct Cancer). Dr. Cannon is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Anal CancerDr. Perry isDistinguished. Learn about Anal Cancer.
- Colorectal CancerDr. Perry isDistinguished. Learn about Colorectal Cancer.
- Familial Colorectal CancerDr. Perry isDistinguished. Learn about Familial Colorectal Cancer.
- Familial Pancreatic CancerDr. Perry isDistinguished. Learn about Familial Pancreatic Cancer.
- Pancreatic CancerDr. Perry isDistinguished. Learn about Pancreatic Cancer.
- Advanced
- Chronic Lymphocytic Leukemia (CLL)
- Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET)
- Lynch SyndromeDr. Perry isAdvanced. Learn about Lynch Syndrome.
- Neuroendocrine TumorDr. Perry isAdvanced. Learn about Neuroendocrine Tumor.
- Stomach CancerDr. Perry isAdvanced. Learn about Stomach Cancer.
- Experienced
- Adult Soft Tissue SarcomaDr. Perry isExperienced. Learn about Adult Soft Tissue Sarcoma.
- Alveolar Soft Part SarcomaDr. Perry isExperienced. Learn about Alveolar Soft Part Sarcoma.
- Appendix CancerDr. Perry isExperienced. Learn about Appendix Cancer.
- Bone TumorDr. Perry isExperienced. Learn about Bone Tumor.
- Carcinoid SyndromeDr. Perry isExperienced. Learn about Carcinoid Syndrome.
- Cholangiocarcinoma (Bile Duct Cancer)Dr. Perry isExperienced. Learn about Cholangiocarcinoma (Bile Duct Cancer).
